← Leaderboards
Shibin Zhou
Johns Hopkins University
$2,815,529
Attributed
$2,815,529
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $364.3K · FY2007–16$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,815,529 · 2
By mechanism
P50$2,815,529 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Martin G Pomper$38,517,075
- Arturo Casadevall$47,974,076
- Richard F. Ambinder$9,273,650
- Elizabeth A. Platz$18,230,919
- Alan Keith Meeker$5,318,574
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseFundingClinical TrialsTumorCancer TherapyResistanceSafetyAntineoplastic AgentsToxic EffectAnimalsTherapeutic AgentsAreaCancer CellMalignant Neoplasm Of Gastrointestinal TractBacterial InfectionsAnthrax Lethal FactorBacteriaAdverse EffectsDrug Effect DisorderEngineeringAttenuatedClostridiumClinical ResearchAnimal Model
Grant awards (10)
Access of Therapeutic Agents to Cancer Cells$320,633
P50 · FY2016 · CA · contact PI
Access of Therapeutic Agents to Cancer Cells$345,202
P50 · FY2015 · CA · contact PI
Access of Therapeutic Agents to Cancer Cells$342,401
P50 · FY2014 · CA · contact PI
Access of Therapeutic Agents to Cancer Cells$340,582
P50 · FY2013 · CA · contact PI
Access of Therapeutic Agents to Cancer Cells$364,256
P50 · FY2012 · CA · contact PI
Optimizing and Monitoring C.novyi Therapy of Metastic Colorectal Cancer$217,834
P50 · FY2011 · CA · contact PI
Optimizing and Monitoring C.novyi Therapy of Metastic Colorectal Cancer$227,324
P50 · FY2010 · CA · contact PI
Optimizing and Monitoring C.novyi Therapy of Metastic Colorectal Cancer$225,458
P50 · FY2009 · CA · contact PI
Optimizing and Monitoring C.novyi Therapy of Metastic Colorectal Cancer$222,831
P50 · FY2008 · CA · contact PI
Optimizing and Monitoring C.novyi Therapy of Metastic Colorectal Cancer$209,008
P50 · FY2007 · CA · contact PI